LDx-RPOC Investigating the potential of rapid diagnostic technology in point-of-care

Linear Diagnostics Limited(LDL), in partnership with NIHR HealthTech Research Centre (HRC) in Diagnostic and Technology Evaluation and the North East Innovation Lab (NEIL) is developing a portable, low-cost, accurate point-of-care diagnostic platform, LDx-RPOC, capable of identifying infections, in a single sample, faster than any commercially available alternative.

Proof of concept work to date has shown successful results for LDL s technologies, providing a fast, accurate diagnostic tests for CT, NG, Covid-19 and UTIs.

Traditional Nucleic Acid Amplification Test (NAAT) based diagnostics require a long time to result, specific trained expertise, and are expensive. Results can take days/weeks and the process is not conducive to patient wellbeing or effective treatment outcomes.

The World Health Organisation (WHO) stipulates tests should be easy to use with minimal training, and results obtained quickly (